Understanding genetic risks for autism in newborns
Core C: Assessment Core
This study is looking at how finding certain genetic markers for autism in newborns can help us understand their development and support parents in making decisions, with the aim of improving early detection and intervention for autism.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10916382 on NIH RePORTER |
What this research studies
This research investigates how identifying genetic variants linked to a higher risk of autism shortly after birth can predict changes in neurodevelopment and autism diagnosis. It involves a cohort of infants, some with identified genetic risks and others without, to explore the impact of genetic diagnosis on parents' experiences and decision-making. The study includes screening for autism at 18 months and comprehensive evaluations at 24 months for those who screen positive. The goal is to improve early detection and intervention strategies for autism.
Who could benefit from this research
Good fit: Ideal candidates for participation are infants identified as having a genetic risk for autism, as well as those without such risks for comparative analysis.
Not a fit: Patients who are older than 11 years or those without any genetic risk factors for autism may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate autism diagnoses, allowing for timely interventions that can improve developmental outcomes for affected children.
How similar studies have performed: Previous research has shown promise in using genetic screening to identify autism risk, indicating that this approach could yield valuable insights.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Kanne, Stephen M — Columbia University Health Sciences
- Study coordinator: Kanne, Stephen M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.